AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative
medical devices for the minimally-invasive treatment of cancer and
peripheral vascular disease, announced today that it has appointed Shawn
P. McCarthy, 40, as Senior Vice President and General Manager of the
Company’s Peripheral Vascular Business Unit. Mr. McCarthy will report to
Jan Keltjens, Chief Executive Officer of AngioDynamics.
“Shawn brings global leadership experiences across critical functions,
managing product platforms in multiple companies and countries. He has a
track record of successfully commercializing new products in
important therapeutic areas, in highly regulated medical device
markets,” said Mr. Keltjens. “Shawn possesses a deep customer
understanding with significant success in marketing and sales. By
joining our team he continues to build our capabilities in the
marketplace and increase our capacity for future growth.”
Mr. McCarthy has more than 18 years of medical device commercial
experience, with his last 10 years being at Johnson & Johnson. He began
his career at Johnson & Johnson in 1998, as a product director for
Cordis Corporation. He has held sales and marketing positions of
increasing responsibility, ultimately leading to his most recent role as
Vice President of Marketing at Cordis for their Endovascular and
Cardiology divisions. Prior to joining Johnson & Johnson, Mr. McCarthy
was the Senior Global Product Manager for the Respiratory Division of
Sunrise Medical, Inc. He received his B.A. and M.B.A. from Syracuse
University.
“I am looking forward to building on our position as the leader in the
endovenous laser market, leveraging the strength of our VenaCure EVLT™
brand, our broader vein interventional business, as well as exciting new
therapies such as our Benephit® system for targeted renal
drug delivery,” said Mr. McCarthy. “We expect to continue advancing our
relationships with physicians to deliver the best therapies available
for their patients. I am committed to creating value for them, our
employees, and our shareholders.”
Mr. McCarthy will relocate to upstate New York where he will join
AngioDynamics on August 17. He replaces Sean Morris, who has served as
SVP and GM of the Peripheral Vascular Unit since June 2008. Mr. Morris
has agreed to assist during the transition period and will leave the
Company when the transition is complete. “I would like to thank Sean
Morris for his important contributions to AngioDynamics during his nine
years of service and wish him the very best in the future,” said Mr.
